From: Genetics and genomics of radiotherapy toxicity: towards prediction
Gene(s) investigated | Cancer | Number | Association(s) | Reference |
---|---|---|---|---|
21 | Esophageal | 81 | XRCC2, GSTP1 | [87] |
TP53 | Lung | 253 | Yes | [88] |
XRCC1 | Prostate | 603 | Yes | [89] |
XRCC1, XRCC3, XPD, GSTM1, GSTT1, MSH2, MLH1, MSH3, MGMT | Breast | 87 | XRCC1, XRCC3, MSH2 | [90] |
59 | NSCLC | 173 | PTGS22, IL1A, IL8, TNF, MIF, NOS3 | [91] |
XRCC1, OGG1, MRCC3 | Breast | 43 | No | [92] |
TGFB1, XRCC1, XRCC2 | Head and neck | 60 | TGFB1, XRCC1, No. risk alleles | [93] |
XRCC1 | Breast | 119 | Yes | [94] |
ATM | Lung | 253 | Yes | [95] |
ATM, GSTP1, SOD2, XPD, XRCC1 | Breast | 69 | No. risk alleles | [96] |
211 | Cervix | 243 | NPAT-ATM, AURKA | [97] |
TGFB1, L10P, C509T, G915C | Breast | 190 | No | [98] |
TGFB1 | Breast | 778 | No | [99] |
MC1R | Mixed | 30 | Yes | [100] |
APEX1, XRCC1, XRCC2, XRCC3, XPD, TP53, P21 | Breast | 409 | TP53 | [101] |
TGFB1 | NSCLC | 164 | Yes | [102] |
XRCC3, RAD51, XRCC5, LIG4, XRCC6 | Head and neck | 88 | XRCC3, XRCC6 | [103] |
XRCC1, APEX1, OGG1, XRCC2, XRCC3, NBN, XPA, ERCC1, XPC, TP53, P21, MDM2 | Prostate | 405 | No | [104] |
TGFB1 | Prostate | 445 | No | [105] |
GSTA1, GSTM1, GSTT1, GSTP1, MPO, SOD2, NOS3, CAT | Breast | 390 | GSTA1, NOS3 | [52] |
VEGF | Prostate | 99 | Yes | [106] |
TGFB1 | Prostate | 141 | Yes | [107] |
3,144 SNPs in 494 genes | Breast | 156 | Associations | [108] |
SOD2, XRCC1, XRCC3 | Prostate | 135 | XRCC1, SOD2, SOD2+XRCC3 | [109] |
ATM, SOD2, XRCC1, XRCC3, TGFB1, RAD21 | Mixed severe reactors | 30 | No. risk alleles | [39] |
TP53, CDKN1A | Breast | 22 | No | [110] |
450 SNPs in 115 genes | Prostate | 197 | SART1, ID3, EPDR1, PAH, XRCC6 | [111] |
999 SNPs in 137 genes | Breast | 399 | CD44, MAD2L2, PTTG1, RAD9A, LIG3 | [69] |
TGFB1, XRCC1, APE1, DHFR, CX3CR1, MTHFR, EPHX1 | Breast | 167 | XRCC1, TGFB1 | [112] |
ATM | Breast | 252 | Yes | [113] |
GSTM1, GSTP1, GSTT1 | Breast | 253 | GSTP1 | [114] |
CAT, SOD2, MPO, NOS3 | Breast | 446 | No | [115] |
XRCC1 | Breast | 247 | Yes | [116] |
TP53, p21 | Breast | 446 | No | [117] |
XRCC3, XRCC2, NBS1 | Breast | 446 | No | [118] |
TGFB1 | Gynae | 78 | No | [119] |
49 | Prostate | 83 | LIG4, ERCC2, CYP2D6 | [120] |
TGFB1, SOD2, XRCC1, XRCC3, APEX, ATM | Breast | 120 | No | [59] |
GSTA1, GSTP1, GSTM1, GSTT1 | Breast | 446 | GSTP1 | [121] |
ERCC4 | Head and neck | 130 | Yes | [122] |
XRCC1, APE1, XPD | Breast | 446 | XRCC1, APE1 | [123] |
TGFB1, SOD2, XRCC1, XRCC3, APEX, ATM | Breast | 52 | TGFB1 | [124] |
XRCC1, XRCC3, OGG1 | Gynae | 62 | No. risk alleles | [125] |
XRCC1 | Breast | 254 | Yes | [126] |
TGFB1 | Breast | 103 | Yes | [127] |
TGFB1, SOD2, XRCC1, XRCC3, APEX | Breast | 41 | No. risk alleles | [128] |
ATM | Breast | 254 | Yes | [129] |
SOD2 | Breast | 80 | No | [130] |
RAD21 | Mixed | 19 | Yes | [131] |